Immunocell Therapeutics is an allogeneic Gamma Delta T-cell therapy company featuring unique, proprietary, end-to-end bioinformatic, AI targeting, and manufacturing technologies to address solid tumors.
We are a clinical-stage, fully integrated biotherapeutics company using its proprietary DIAMOND® artificial intelligence (AI) 2.0 target discovery engine to develop and commercialize cell therapies focusing on immuno-oncology. Immunocell Therapeutics is developing a multi-indication allogeneic cell therapy platform that exploits the natural potency of Gamma Delta T-cells to target solid tumors. Immunocell's DIAMOND® AI is where data science meets target identification to dramatically compress the years and hundreds of millions of dollars required to develop a live drug.
Company Details
- Employees
- 5
- Address
- Solid Tumors.
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.imcti.com
Immunocell Therapeutics Inc Questions
Immunocell Therapeutics Inc's website is http://www.imcti.com
Immunocell Therapeutics Inc's LinkedIn profile is https://www.linkedin.com/company/immunocell-therapeutics-inc
Immunocell Therapeutics Inc has
5 employees.
View email and phone details for 5
employees at Immunocell Therapeutics Inc.
Immunocell Therapeutics Inc's industry is
Biotechnology Research
Immunocell Therapeutics Inc's top competitors are
Alumerix,
Immunocellular Therapeutics Ltd,
Eight6seven,
Mongoose Bio Inc.,
Akiram Therapeutics,
Msk Infotek,
Biohouston,
Yap Therapeutics, Inc.,
Genesis Biotechnology Group,
Vgxi.
Immunocell Therapeutics Inc's categories are Biotechnology Research
